Press releases
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
- Labcorp to Announce First Quarter Financial Results on April 25, 2024
- Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
- Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
- Labcorp Launches Weight Loss Management Testing Solutions
- PINNACLE FERTILITY PARTNERS WITH LABCORP TO ENHANCE GENETIC TESTING SERVICES
- Labcorp Announces 2023 Fourth Quarter and Full Year Results
- Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine
- Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
- Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
More ▼
Key statistics
On Thursday, Laboratory Corporation of America Holdings (LAB:BER) closed at 199.00, -5.24% below its 52-week high of 210.00, set on Feb 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 199.00 |
---|---|
High | 199.00 |
Low | 199.00 |
Bid | 202.00 |
Offer | 204.00 |
Previous close | 197.00 |
Average volume | 1.00 |
---|---|
Shares outstanding | 84.10m |
Free float | 83.89m |
P/E (TTM) | 51.86 |
Market cap | 18.37bn USD |
EPS (TTM) | 4.21 USD |
Annual div (ADY) | 2.65 EUR |
---|---|
Annual div yield (ADY) | 1.35% |
Div ex-date | Feb 26 2024 |
Div pay-date | Mar 13 2024 |
Data delayed at least 15 minutes, as of Mar 28 2024 07:08 BST.
More ▼